In the News

1841 News Items found
Event
Hundreds of high school students and teachers from the New York City area attend the annual seminar.
Webcast of 2012 Major Trends in Modern Cancer Research
For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
Q&A
Pictured: Ping Chi
At Work: Physician-Scientist Ping Chi
Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
Pictured: Scott Armstrong
Scott Armstrong and Kitai Kim Named to Endowed Chairs
Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
Announcement
Pictured: Zuckerman Research Center
Pioneering Cancer Research Complex Nears Completion
Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.
In the Lab
Pictured: Structure of Synthesized Erythropoietin
Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time
Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.
Announcement
Pictured: Alexander Rudensky
Alexander Rudensky Appointed Immunology Program Chair
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Snapshot
Pictured: Tunneling Nanotubes
Tunneling Nanotubes Connect Cancer Cells
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
In the Lab
Pictured: Ross Levine
Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective
Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.
In the Lab
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
In the Lab
Pictured: Filippo Giancotti
Researchers Shed Light on Why Some Breast Cancers Spread to the Lungs
A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.